65G Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - NextCell Pharma AB

Watchlist Manager

Watchlist

Price: 0.0858 EUR -5.71% Market Closed

Market Cap: €10.3m

	NextCell Pharma AB F:65G	SE
G	Greenbrier Companies Inc F:G90	US
	Coveo Solutions Inc F:I94	CA
U	Uniqa Insurance Group AG PSE:UQA	AT
A	Anika Therapeutics Inc F:AKP	US
A	Avient Corp XMUN:PY9	US

Profitability Summary

NextCell Pharma AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-187%

Negative 3Y Average Gross Margin

-174%

Declining Gross Margin

-33% > -187%

Negative Operating Margin

-378%

Negative 3Y Average Operating Margin

-383%

Operating Margin is Increasing

-539% > -378%

Negative Net Margin

-372%

Negative 3Y Average Net Margin

-374%

Net Margin is Increasing

-529% > -372%

Negative Free Cash Flow Margin

-408%

Negative 3Y Average Free Cash Flow Margin

-409%

Free Cash Flow Margin is Increasing

-571% > -408%

Negative ROE

-92%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-127%

ROIC is Increasing

-170% > -153%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.